case_images: PMC8458931_01
case_images: Location of ABCC8 mutations in the SUR1 protein (A) and KCNJ11 mutations in the Kir6.2 protein (B) identified in 27 Vietnamese patients with NDM. TMD, transmembrane domain.
case_images: fendo-12-727083-g001.jpg
case_images: PMC8458931_01_fendo-12-727083-g001.jpg
case_images: f1
case_images: Eight KCNJ11 mutations identified in this study are located in the N- and C-terminal regions (Figure 1B), which form the ATP binding pocket of Kir6.2.
case_images: The glycemic control (A) and reduction of HbA1C levels (B) with switching from insulin to sulfonylurea therapy. SU, sulfonylurea.
case_images: fendo-12-727083-g002.jpg
case_images: PMC8458931_01_fendo-12-727083-g002.jpg
case_images: f2
case_images: Excellent glycemic control was maintained after commencing SU therapy (Figure 2A), which is similar to other reports.